Drug Trial Radar · NCT01327638
Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
Last checked: Nov 19, 2026Latest source record: May 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21,108
Actual
Start
Feb 15, 2011
Primary completion
Sep 24, 2018
Study completion Dec 6, 2018
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Apr 1, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is intended to provide additional post-marketing safety data regarding the use of etoricoxib for the indication of ankylosing spondylitis.
Conditions
- Spondylarthropathies; Spondylitis, Ankylosing
Interventions
etoricoxibDrug
Patients with SpA/AS who took etoricoxib
Other COX-2 inhibitorDrug
Patients with SpA/AS who took other COX-2 inhibitors
nsNSAIDsDrug
Patients with SpA/AS who took nsNSAIDs
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with Characteristics of inflammatory SPA/ASTime frame: Over a 12 year period (2001-2013)
- Number of patients who used etoricoxibTime frame: Up to 7 1/2 years (Q3 2005 - 2013)
- Number of patients who used other COX-2 inhibitorsTime frame: Up to 7 1/2 years (Q3 2005 - 2013)
- Number of patients who used nsNSAIDsTime frame: Up to 7 1/2 years (Q3 2005 - 2013)
- Number of clinical outcomes of special interestTime frame: Up to 7 1/2 years (Q3 2005 - 2013)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.